Literature DB >> 10877852

Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity.

M B Smith1, M L Lamb, J Tirado-Rives, W L Jorgensen, C J Michejda, S K Ruby, R H Smith.   

Abstract

A computational model of the non-nucleoside inhibitor 8-Cl TIBO complexed with HIV-1 reverse transcriptase (RT) was constructed in order to determine the binding free energies. Using Monte Carlo simulations, both free energy perturbation and linear response calculations were carried out for the transformation of wild-type RT to two key mutants, Y181C and L100I. The newer linear response method estimates binding free energies based on changes in electrostatic and van der Waals energies and solvent-accessible surface areas. In addition, the change in stability of the protein between the folded and unfolded states was estimated for each of these mutations, which are known to emerge upon treatment with the inhibitor. Results from the calculations revealed that there is a large hydrophobic contribution to protein stability in the native, folded state. The calculated absolute free energies of binding from both the linear response, and also the more rigorous free energy perturbation method, gave excellent agreement with the experimental differences in activity. The success of the relatively rapid linear response method in predicting experimental activities holds promise for estimating the activity of the inhibitors not only against the wild-type RT, but also against key protein variants whose emergence undermines the efficacy of the drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877852     DOI: 10.1093/protein/13.6.413

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  6 in total

1.  Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenz.

Authors:  Marilyn B Kroeger Smith; Lenea H Rader; Amanda M Franklin; Emily V Taylor; Katie D Smith; Richard H Smith; Julian Tirado-Rives; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2007-12-23       Impact factor: 2.823

2.  High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.

Authors:  Reynel Cancio; Romano Silvestri; Rino Ragno; Marino Artico; Gabriella De Martino; Giuseppe La Regina; Emmanuele Crespan; Samantha Zanoli; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

4.  Docking mode of delvardine and its analogues into the p66 domain of HIV-1 reverse transcriptase: screening using molecular mechanics-generalized born/surface area and absorption, distribution, metabolism and excretion properties.

Authors:  Dipankar Sengupta; Deeptak Verma; Pradeep K Naik
Journal:  J Biosci       Date:  2007-12       Impact factor: 1.826

5.  Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.

Authors:  Elena N Peletskaya; Alex A Kogon; Steven Tuske; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Simulating metabolism with statistical thermodynamics.

Authors:  William R Cannon
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.